Global STD Diagnosis Market Report: Forecast to 2022 - Market is Growing at a Faster Pace Owing to the Rising Incidences of Unprotected Sex - ResearchAndMarkets.com

DUBLIN--()--The "Global STD Diagnosis Market Research and Forecasts 2017-2022" report has been added to ResearchAndMarkets.com's offering.

The Global STD (Sexually Transmitted Disease) Diagnosis Market is expected to grow at a CAGR of 8.7% during the forecast period (2017-2022).

Global STD Diagnosis Market is growing at a faster pace owing to the rising incidences of unprotected sex, lack of awareness and so forth. The rising number of patients suffering from STD includes people from age group of 15 years to 24 years. Recommendations from various regulatory authorities for annual STD screening for sexually active men and women are expected to further fuel the demand for STD testing. STD screening services are now widely covered under healthcare services and are likely to augment the growth of the global STD testing market. Regulatory authorities such as the WHO, have outlined strategies for the prevention and control of STDs.

Research activities are being carried out to understand the growing prevalence of STDs, particularly Syphilis, among bisexual men and gay. All of these factors are anticipated to boost the growth of the global STD (sexually transmitted disease) diagnosis market during the forecast period.

Moreover, lack of knowledge related to STD and poor infrastructure provision such as labs, and equipment in underdeveloped countries such as West Africa acts as a hindering agent and blocks the growth of the global STD (Sexually Transmitted Disease) Diagnosis market.

Key Topics Covered

1. Report Summary

2. Market Overview and Insights

3. Market Determinant

4. Market Segmentation

5. Competitive Landscape

6. Regional Analysis

7. Company Profiles

  • Abbott Laboratories
  • Affymetrix Inc.
  • Alere Inc.
  • Aposcience Ag
  • BCR Biotech Inc.
  • Becton Dickinson and Company
  • Biocartis Sa
  • Biomerieux
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Danaher Corporation
  • Diasorin
  • Exogen Biotechnology, Inc.
  • Genmark Diagnostics
  • Hologic, Inc
  • Orasure Technologies
  • Qualigen, Inc.
  • Quidel Corporation
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/f3xqcm/global_std?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing